Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism
- 1 October 1999
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 20 (10) , 418-423
- https://doi.org/10.1016/s0165-6147(99)01380-2
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signalingProgress in Neurobiology, 1998
- Regulation of Secretion of Alzheimer Amyloid Precursor Protein by the Mitogen‐Activated Protein Kinase CascadeJournal of Neurochemistry, 1998
- Specific role for protein kinase Cα in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblastsNeuroscience Letters, 1998
- Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brainNeurobiology of Aging, 1997
- Phorbol Esters but Not the Cholinergic Agonists Oxotremorine‐M and Carbachol Increase Release of the Amyloid Precursor Protein in Cultured Rat Cortical NeuronsJournal of Neurochemistry, 1996
- Intracellular Cyclic AMP Inhibits Constitutive and Phorbol Ester‐Stimulated Secretory Cleavage of Amyloid Precursor ProteinJournal of Neurochemistry, 1996
- Mechanisms of Neuronal Degeneration in Alzheimer's DiseaseNeuron, 1996
- Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain SecretionJournal of Biological Chemistry, 1996
- Cholinesterase inhibitors increase secretion of APPs in rat brain cortexNeuroReport, 1995
- Muscarinic Regulation of Alzheimer's Disease Amyloid Precursor Protein Secretion and Amyloid β-Protein Production in Human Neuronal NT2N CellsJournal of Biological Chemistry, 1995